59 related articles for article (PubMed ID: 1672641)
1. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity.
Titus RG; Müller I; Kimsey P; Cerny A; Behin R; Zinkernagel RM; Louis JA
Eur J Immunol; 1991 Mar; 21(3):559-67. PubMed ID: 1672641
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase A is a pleiotropic and essential enzyme for Leishmania survival and virulence.
Zhang O; Hsu FF; Xu W; Pawlowic M; Zhang K
Mol Microbiol; 2013 Nov; 90(3):489-501. PubMed ID: 23980754
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipid degradation in Leishmania (Leishmania) amazonensis.
Pillai AB; Xu W; Zhang O; Zhang K
PLoS Negl Trop Dis; 2012; 6(12):e1944. PubMed ID: 23285302
[TBL] [Abstract][Full Text] [Related]
5. Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence.
Pawlowic MC; Zhang K
Mol Biochem Parasitol; 2012 Nov; 186(1):11-20. PubMed ID: 22954769
[TBL] [Abstract][Full Text] [Related]
6. Developmentally regulated sphingolipid degradation in Leishmania major.
Zhang O; Xu W; Balakrishna Pillai A; Zhang K
PLoS One; 2012; 7(1):e31059. PubMed ID: 22299050
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid degradation by Leishmania major is required for its resistance to acidic pH in the mammalian host.
Xu W; Xin L; Soong L; Zhang K
Infect Immun; 2011 Aug; 79(8):3377-87. PubMed ID: 21576322
[TBL] [Abstract][Full Text] [Related]
8. Phenylalanine hydroxylase (PAH) from the lower eukaryote Leishmania major.
Lye LF; Kang SO; Nosanchuk JD; Casadevall A; Beverley SM
Mol Biochem Parasitol; 2011 Jan; 175(1):58-67. PubMed ID: 20887755
[TBL] [Abstract][Full Text] [Related]
9. Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage.
Morales MA; Pescher P; Späth GF
Eukaryot Cell; 2010 Jan; 9(1):22-30. PubMed ID: 19801421
[TBL] [Abstract][Full Text] [Related]
10. Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice.
Reguera RM; Balaña-Fouce R; Showalter M; Hickerson S; Beverley SM
Mol Biochem Parasitol; 2009 May; 165(1):48-56. PubMed ID: 19393161
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major.
Capul AA; Hickerson S; Barron T; Turco SJ; Beverley SM
Infect Immun; 2007 Sep; 75(9):4629-37. PubMed ID: 17606605
[TBL] [Abstract][Full Text] [Related]
12. Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania.
Zhang K; Pompey JM; Hsu FF; Key P; Bandhuvula P; Saba JD; Turk J; Beverley SM
EMBO J; 2007 Feb; 26(4):1094-104. PubMed ID: 17290222
[TBL] [Abstract][Full Text] [Related]
13. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis.
Zhang K; Hsu FF; Scott DA; Docampo R; Turk J; Beverley SM
Mol Microbiol; 2005 Mar; 55(5):1566-78. PubMed ID: 15720561
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.
Theodos CM; Morris RV; Bishop JV; Jones JD; McMaster WR; Titus RG
Infect Immun; 2004 Aug; 72(8):4486-93. PubMed ID: 15271907
[TBL] [Abstract][Full Text] [Related]
15. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts.
Späth GF; Garraway LA; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9536-41. PubMed ID: 12869694
[TBL] [Abstract][Full Text] [Related]
16. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.
Späth GF; Epstein L; Leader B; Singer SM; Avila HA; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9258-63. PubMed ID: 10908670
[TBL] [Abstract][Full Text] [Related]
17. Virulent or avirulent (dhfr-ts-) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro.
Brodskyn C; Beverley SM; Titus RG
Clin Exp Immunol; 2000 Feb; 119(2):299-304. PubMed ID: 10632666
[TBL] [Abstract][Full Text] [Related]
18. Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells.
Mary C; Auriault V; Faugère B; Dessein AJ
Infect Immun; 1999 Nov; 67(11):5559-66. PubMed ID: 10531200
[TBL] [Abstract][Full Text] [Related]
19. Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice.
Babai B; Louzir H; Cazenave PA; Dellagi K
Clin Exp Immunol; 1999 Jul; 117(1):123-9. PubMed ID: 10403925
[TBL] [Abstract][Full Text] [Related]
20. Polarized helper-T-cell responses against Leishmania major in the absence of B cells.
Brown DR; Reiner SL
Infect Immun; 1999 Jan; 67(1):266-70. PubMed ID: 9864225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
